COMPLIANCY TO LEVOTHYROXINE TREATMENT AND THE RATE OF DISEASE CONTROL FOR PATIENTS WITH HYPOTHYROIDISM IN DUHOK CITY
Abstract
https://doi.org/10.31386/dmj.2024.18.2.9
Background: Hypothyroidism is one of the most prevalent endocrine diseases, affecting nearly 200 million people globally, with around 60% of those affected remaining undiagnosed. The incidence of hypothyroidism has been shown to have increased recently, becoming a worldwide health problem. It accounts for 30-40% of the patients seen in endocrinology departments and clinics. Iodine deficiency is the most prevalent cause of hypothyroidism, with data showing that around 2 billion people suffer from insufficient iodine intake.ke
Materials and Methods: In this cross-sectional study, we enrolled 309 adults with hypothyroidism who had been receiving Levothyroxine for 8 weeks or more at Azadi General & Teaching Hospital from July 10, 2023, to August 25, 2023. The planned sample size was chosen to facilitate accurate estimates of the rate of control and adherence to treatment. No formal study visits were conducted, and patients were approached for participation during their routine clinic visits.
Results: In our study of 309 hypothyroidism patients treated with levothyroxine for 8 weeks to 25 years, we found that 54.37% achieved optimal disease control, 37.22% did not achieve control, and 8.41% were overcorrected. Patients with full adherence to levothyroxine had significantly better TSH control compared to those with poor adherence (p < 0.001).
Conclusions: In this study, we observed poor treatment compliance rates, with only around half of the patients achieving disease control. Additionally, a significant proportion of patients were found to be overweight or obese.
Downloads
References
1. Alzahrani AS, Al Mourad M, Hafez K, Almaghamsy AM, Alamri FA, Al Juhani NR, et al. Diagnosis and management of hypothyroidism in Gulf Cooperation Council (GCC) countries. Adv Ther. 2020 Jul;37(7):3097-3111. doi: 10.1007/s12325-020-01382-2. Epub 2020 Jun 1. PMID: 32488658; PMCID: PMC7467410..
2. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated Thyroid Cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020. PMID: 26462967; PMCID: PMC4739132.
3. Qureshi ZN, Kumar D, Ismail M, Ejaz M, Rashid A. Hypothyroid disorders in UAE community, single centre retrospective study. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS). 2021 Sep;20(9 Ser.15):12-16. e-ISSN: 2279-0853, p-ISSN: 2279-0861..
4. Galofré JC, García-Mayor RV, Fluiters E, Fernàndez-Calvet L, Rego A, Pàramo C, et al. Incidence of different forms of thyroid dysfunction and its degrees in an iodine sufficient area. Thyroidology. 1994 Aug;6(2):49-54. PMID: 7536450.
5. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb;87(2):489-99. doi: 10.1210/jcem.87.2.8182. PMID: 11836274.
6. Bemben DA, Hamm RM, Morgan L, Winn P, Davis A, Barton E. Thyroid disease in the elderly. Part 2. Predictability of subclinical hypothyroidism. J Fam Pract. 1994 Jun;38(6):583-8. PMID: 8195732.
7. Wyne KL, Nair L, Schneiderman CP, Pinsky B, Antunez Flores O, Guo D, et al. Hypothyroidism prevalence in the United States: A retrospective study combining National Health and Nutrition Examination Survey and Claims ata, 2009-2019. J Endocr Soc. 2022 Nov 10;7(1):bvac172. doi: 10.1210/jendso/bvac172. PMID: 36466005; PMCID: PMC9706417.
8. de Benoist B, McLean E, Andersson M, Rogers L. Iodine deficiency in 2007: global progress since 2003. Food Nutr Bull. 2008 Sep;29(3):195-202. doi: 10.1177/156482650802900305. PMID: 18947032.
9. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51. doi: 10.1093/bmb/ldr030. PMID: 21893493.
10. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017 Sep 23;390(10101):1550-1562. doi: 10.1016/S0140-6736(17)30703-1. Epub 2017 Mar 20. PMID: 28336049; PMCID: PMC6619426.
11. Gaitonde DY, Rowley KD, Sweeney LB. Hypothyroidism: an update. Am Fam Physician. 2012 Aug 1;86(3):244-51. PMID: 22962987.
12. Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001 Jul 26;345(4):260-5. doi: 10.1056/NEJM200107263450406. PMID: 11474665.
13. La Vignera S, Vita R. Thyroid dysfunction and semen quality. Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418775241. doi: 10.1177/2058738418775241. PMID: 29737216; PMCID: PMC5946587.
14. La Vignera S, Vita R, Condorelli RA, Mongioì LM, Presti S, Benvenga S, et al. Impact of thyroid disease on testicular function. Endocrine. 2017 Dec;58(3):397-407. doi: 10.1007/s12020-017-1303-8. Epub 2017 Apr 20. PMID: 28429281.
15. Hegedüs L, Bianco AC, Jonklaas J, Pearce SH, Weetman AP, Perros P. Primary hypothyroidism and quality of life. Nat Rev Endocrinol. 2022 Apr;18(4):230-242. doi: 10.1038/s41574-021-00625-8. Epub 2022 Jan 18. PMID: 35042968; PMCID: PMC8930682.
16. de Benoist B, McLean E, Andersson M, Rogers L. Iodine deficiency in 2007: global progress since 2003. Food Nutr Bull. 2008 Sep;29(3):195-202. doi: 10.1177/156482650802900305. PMID: 18947032.
17. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51. doi: 10.1093/bmb/ldr030. PMID: 21893493.
18. Gaitonde DY, Rowley KD, Sweeney LB. Hypothyroidism: an update. Am Fam Physician. 2012 Aug 1;86(3):244-51. PMID: 22962987.
19. Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001 Jul 26;345(4):260-5. doi: 10.1056/NEJM200107263450406. PMID: 11474665.
20. La Vignera S, Vita R. Thyroid dysfunction and semen quality. Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418775241. doi: 10.1177/2058738418775241. PMID: 29737216; PMCID: PMC5946587.
21. El Helou S, Hallit S, Awada S, Al-Hajje A, Rachidi S, Bawab W, et al. Adherence to levothyroxine among patients with hypothyroidism in Lebanon. East Mediterr Health J. 2019 Apr 25;25(3):149-159. doi: 10.26719/emhj.18.022. PMID: 31054225.
22. Al Kindi RM, Al Riyami RA, Juma SY, Al Kiyumi MI. Adherence to levothyroxine treatment among patients with hypothyroidism in Oman: a national cross-sectional study. Curr Med Res Opin. 2023 Oct;39(10):1313-1319. doi: 10.1080/03007995.2023.2250256. Epub 2023 Aug 29. PMID: 37605332.
23. Alofi RM, Alrohaily LS, Jan RA, Alsaedi SL, Mahrous FA, Alreefi MM. Adherence to levothyroxine treatment among patients with hypothyroidism in Madinah, Saudi Arabia: A cross-cectional study. Cureus. 2023 Jun 20;15(6):e40686. doi: 10.7759/cureus.40686. PMID: 37485132; PMCID: PMC10358293.
24. Cappelli C, Castello R, Marini F, Paoletta A, Marchetti M, Saullo M, et al. Adherence to levothyroxine treatment among patients with hypothyroidism: A Northeastern Italian Survey. Front Endocrinol (Lausanne). 2018 Nov 23;9:699. doi: 10.3389/fendo.2018.00699. PMID: 30532737; PMCID: PMC6265311.
25. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000 Feb 28;160(4):526-34. doi: 10.1001/archinte.160.4.526. PMID: 10695693.
26. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract. 1993 Mar;43(368):107-9. PMID: 8323787; PMCID: PMC1372330.
27. Ahmed JH, AL-Emara ZN and Mansour AA. Timing of levothyroxine in the treatment of primary hypothyroidism. British Journal of Medicine & Medical Research. 2016: 12(9): 1-6. Article no.BJMMR.22757 ISSN: 2231-0614, NLM ID: 101570965.
28. Bolk N, Visser TJ, Kalsbeek A, van Domburg RT, Berghout A. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients. Clin Endocrinol (Oxf). 2007 Jan;66(1):43-8. doi: 10.1111/j.1365-2265.2006.02681.x. PMID: 17201800.
29. Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JG, Berghout A. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010 Dec 13;170(22):1996-2003. doi: 10.1001/archinternmed.2010.436. PMID: 21149757.
30. Ríos-Prego M, Anibarro L, Sánchez-Sobrino P. Relationship between thyroid dysfunction and body weight: a not so evident paradigm. Int J Gen Med. 2019 Aug 23;12:299-304. doi: 10.2147/IJGM.S206983. PMID: 31692525; PMCID: PMC6711558.
© Duhok Medical Journal (DMJ), College of Medicine, University of Duhok, Iraq.
The contents of this journal, including articles, figures, and tables, are the intellectual property of their respective authors and the Duhok Medical Journal. Articles are published under a Creative Commons Attribution–NoDerivatives (CC BY-ND) license, permitting sharing and distribution with proper citation, provided that no modifications are made and the original work is properly credited.
Duhok Medical Journal (DMJ)
College of Medicine, University of Duhok
Duhok, Iraq
Email: [email protected]
